163 related articles for article (PubMed ID: 2912983)
21. Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins.
Lundberg C; Marceau F; Huey R; Hugli TE
Immunopharmacology; 1986 Oct; 12(2):135-43. PubMed ID: 3490457
[TBL] [Abstract][Full Text] [Related]
22. Complement C5a receptor assay for high throughput screening.
Harris SR; Garlick RK; Miller JJ; Harney HN; Monroe PJ
J Recept Res; 1991; 11(1-4):115-28. PubMed ID: 1886076
[TBL] [Abstract][Full Text] [Related]
23. Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states.
Siciliano SJ; Rollins TE; Springer MS
J Biol Chem; 1990 Nov; 265(32):19568-74. PubMed ID: 2123189
[TBL] [Abstract][Full Text] [Related]
24. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
[TBL] [Abstract][Full Text] [Related]
25. Identification of an antigenic epitope and receptor binding domain of human C5a.
Johnson RJ; Tamerius JD; Chenoweth DE
J Immunol; 1987 Jun; 138(11):3856-62. PubMed ID: 2438329
[TBL] [Abstract][Full Text] [Related]
26. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
Farkas I; Baranyi L; Liposits ZS; Yamamoto T; Okada H
Neuroscience; 1998 Oct; 86(3):903-11. PubMed ID: 9692726
[TBL] [Abstract][Full Text] [Related]
27. Processing of C5a by human polymorphonuclear leukocytes.
Hetland G; Pfeifer PH; Hugli TE
J Leukoc Biol; 1998 Apr; 63(4):456-62. PubMed ID: 9544575
[TBL] [Abstract][Full Text] [Related]
28. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
29. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
Van Epps DE; Simpson SJ; Johnson R
J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
[TBL] [Abstract][Full Text] [Related]
30. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
Barker MD; Jose PJ; Williams TJ; Burton DR
Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
[TBL] [Abstract][Full Text] [Related]
31. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity.
Johnson RJ; Chenoweth DE
J Biol Chem; 1985 Aug; 260(18):10339-45. PubMed ID: 2410424
[TBL] [Abstract][Full Text] [Related]
32. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
Kawai M; Quincy DA; Lane B; Mollison KW; Or YS; Luly JR; Carter GW
J Med Chem; 1992 Jan; 35(2):220-3. PubMed ID: 1732540
[TBL] [Abstract][Full Text] [Related]
33. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.
Boulay F; Mery L; Tardif M; Brouchon L; Vignais P
Biochemistry; 1991 Mar; 30(12):2993-9. PubMed ID: 2007135
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
van Epps DE; Chenoweth DE
J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
[TBL] [Abstract][Full Text] [Related]
35. The chemotactic receptor for human C5a anaphylatoxin.
Gerard NP; Gerard C
Nature; 1991 Feb; 349(6310):614-7. PubMed ID: 1847994
[TBL] [Abstract][Full Text] [Related]
36. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of cytosolic free Ca2+ in C5a-stimulated neutrophils: loss of receptor-modulated Ca2+ stores and Ca2+ uptake in granule-free cytoplasts.
Gennaro R; Pozzan T; Romeo D
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1416-20. PubMed ID: 6324190
[TBL] [Abstract][Full Text] [Related]
38. Complement C5a receptor antagonism by protamine and poly-L-Arg on human leukocytes.
Olsen UB; Selmer J; Kahl JU
Complement; 1988; 5(3):153-62. PubMed ID: 3180741
[TBL] [Abstract][Full Text] [Related]
39. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
40. Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.
Marasco WA; Becker KM; Feltner DE; Brown CS; Ward PA; Nairn R
Biochemistry; 1985 Apr; 24(9):2227-36. PubMed ID: 3995012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
